Use of Glucocorticoids in Patients With Cancer: Potential Benefits, Harms, and Practical Considerations for Clinical Practice
Authors:
- 30 July 2022
- journal article
- review article
- Published by Elsevier in Practical Radiation Oncology
- Vol. 13 (1) , 28-40
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Reduction of Cancer-Related Fatigue With Dexamethasone: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Advanced CancerJournal of Clinical Oncology, 2013
- The Neuropsychiatric Complications of Glucocorticoid Use: Steroid Psychosis RevisitedPsychosomatics, 2012
- Corticosteroids in brain cancer patients: benefits and pitfallsExpert Review of Clinical Pharmacology, 2011
- Superior Vena Cava Syndrome with Malignant CausesNew England Journal of Medicine, 2007
- Calcium plus Vitamin D Supplementation and the Risk of FracturesNew England Journal of Medicine, 2006
- Management of bone metastases in cancer: A reviewCritical Reviews in Oncology/Hematology, 2005
- Pharmacokinetics and Pharmacodynamics of Systemically Administered GlucocorticoidsClinical Pharmacokinetics, 2005
- Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trialJournal of Pain and Symptom Management, 2004
- Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trialEuropean Journal of Cancer, 1994
- Association of Adrenocorticosteroid Therapy and Peptic-Ulcer DiseaseNew England Journal of Medicine, 1983